Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wookyung Chung

Showing results (101-110 of 106) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 106 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 8, 2015
The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantationJuhan Lee, Kyu Ha Huh, Yongjung Park, et al.
BMC Nephrology|June 3, 2014
KNOW-KT (KoreaN cohort study for outcome in patients with kidney transplantation: a 9-year longitudinal cohort study): study rationale and methodologyJaeseok Yang, Joongyup Lee, Kyu Ha Huh, et al.
BMC Nephrology|June 3, 2014
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methodsKook-Hwan Oh, Sue Kyung Park, Hayne Cho Park, et al.
Kidney Research and Clinical Practice|January 12, 2023
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration periodHyuk Huh, Yong Soo Kim, Wookyung Chung, et al.
Kidney Research and Clinical Practice|October 9, 2024
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final reportHayne Cho Park, Yong Chul Kim, Hyunsuk Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2019
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III StudyYaerim Kim, Su-Kil Park, Won Yong Cho, et al.
Pageof 11

Showing results (101-110 of 106) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 106 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 8, 2015
The clinicopathological relevance of pretransplant anti-angiotensin II type 1 receptor antibodies in renal transplantationJuhan Lee, Kyu Ha Huh, Yongjung Park, et al.
BMC Nephrology|June 3, 2014
KNOW-KT (KoreaN cohort study for outcome in patients with kidney transplantation: a 9-year longitudinal cohort study): study rationale and methodologyJaeseok Yang, Joongyup Lee, Kyu Ha Huh, et al.
BMC Nephrology|June 3, 2014
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methodsKook-Hwan Oh, Sue Kyung Park, Hayne Cho Park, et al.
Kidney Research and Clinical Practice|January 12, 2023
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration periodHyuk Huh, Yong Soo Kim, Wookyung Chung, et al.
Kidney Research and Clinical Practice|October 9, 2024
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final reportHayne Cho Park, Yong Chul Kim, Hyunsuk Kim, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 22, 2019
Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III StudyYaerim Kim, Su-Kil Park, Won Yong Cho, et al.
Pageof 11